Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novo Nordisk A/S Gets FDA Approval for Medic Pen in United States-DJ


Monday, 4 Nov 2013 02:20am EST 

Dow Jones reported that the United States (US) Food and Drug Administration (FDA) has approved Novo Nordisk A/S' prefilled insulin pens NovoRapid FlexTouch and Levemir FlexTouch. Also, Levemir FlexTouch has just been approved by the Canadian health authorities, Health Canada. Novo Nordisk plans to make FlexTouch available in the US within 2014. 

Company Quote

45.43
0.48 +1.07%
21 Oct 2014